We are live on ! Find out more
GI

GAMMA Investing Portfolio holdings

AUM $2.69B
1-Year Est. Return 42.78%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
+42.78%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$249M
Cap. Flow
+$113M
Cap. Flow %
7.12%
Top 10 Hldgs %
25.66%
Holding
3,941
New
148
Increased
2,113
Reduced
1,207
Closed
172

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$13.5M
2
NVDA icon
NVIDIA
NVDA
+$7.56M
3
AMZN icon
Amazon
AMZN
+$4.53M
4
SUB icon
iShares Short-Term National Muni Bond ETF
SUB
+$3.88M
5
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$3.61M

Top Sells

Rank Stock Value
1
JEPI icon
JPMorgan Equity Premium Income ETF
JEPI
+$5.77M
2
IBDQ
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
+$5.06M
3
IBHF icon
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
+$4.61M
4
PFF icon
iShares Preferred and Income Securities ETF
PFF
+$4.27M
5
IBHG icon
iShares iBonds 2027 Term High Yield and Income ETF
IBHG
+$3.85M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Financials 13.46%
3 Consumer Discretionary 8.83%
4 Industrials 8.51%
5 Healthcare 7.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNEX icon
1326
StoneX
SNEX
$7.94B
$91.6K 0.01%
2,261
+591
+35% +$22.2K
BMRN icon
1327
BioMarin Pharmaceuticals
BMRN
$12.4B
$91.6K 0.01%
1,666
-1,463
-47% -$86.2K
FTI icon
1328
TechnipFMC
FTI
$27.3B
$91.6K 0.01%
2,659
-227
-8% -$6.85K
GNW icon
1329
Genworth Financial
GNW
$3.71B
$91.6K 0.01%
11,770
+2,679
+29% +$18.7K
FBT icon
1330
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.83B
$91.3K 0.01%
566
– –
BLTE
1331
Belite Bio
BLTE
$6.54B
$91.3K 0.01%
1,582
-267
-14% -$16.3K
MLI icon
1332
Mueller Industries
MLI
$15.2B
$91.2K 0.01%
2,296
+16
+0.7% +$604
SR icon
1333
Spire
SR
$4.85B
$91.2K 0.01%
1,249
+522
+72% +$39.1K
UBSI icon
1334
United Bankshares
UBSI
$6.62B
$91K 0.01%
2,497
+141
+6% +$4.95K
THG icon
1335
Hanover Insurance
THG
$7.98B
$90.9K 0.01%
535
+36
+7% +$6.01K
RIO icon
1336
Rio Tinto
RIO
$164B
$90.8K 0.01%
1,556
-990
-39% -$58.5K
AA icon
1337
Alcoa
AA
$13.2B
$90.4K 0.01%
3,064
+766
+33% +$20.7K
FLGT icon
1338
Fulgent Genetics
FLGT
$527M
$90.4K 0.01%
4,546
+144
+3% +$2.81K
SUPN icon
1339
Supernus Pharmaceuticals
SUPN
$2.77B
$90.2K 0.01%
2,861
+1,541
+117% +$49.4K
PTEN icon
1340
Patterson-UTI
PTEN
$3.76B
$90.2K 0.01%
15,207
+1,615
+12% +$9.72K
CAJ
1341
DELISTED
Canon, Inc.
CAJ
$90.1K 0.01%
3,105
-226
-7% -$6.56K
ARES icon
1342
Ares Management
ARES
$30.9B
$90.1K 0.01%
520
+245
+89% +$38.7K
ANIP icon
1343
ANI Pharmaceuticals
ANIP
$1.78B
$90K 0.01%
1,379
-40
-3% -$2.6K
HR icon
1344
Healthcare Realty
HR
$6.84B
$90K 0.01%
5,672
-2,495
-31% -$37.9K
FTLS icon
1345
First Trust Long/Short Equity ETF
FTLS
$2.5B
$89.9K 0.01%
1,357
– –
ROIV icon
1346
Roivant Sciences
ROIV
$26.2B
$89.9K 0.01%
7,978
+1,485
+23% +$16.1K
SKYY icon
1347
First Trust Cloud Computing ETF
SKYY
$3.12B
$89.8K 0.01%
738
– –
GLOB icon
1348
Globant
GLOB
$1.61B
$89.8K 0.01%
988
+246
+33% +$26.3K
CNR
1349
Core Natural Resources Inc
CNR
$4.45B
$89.7K 0.01%
1,286
+29
+2% +$2.06K
DGRW icon
1350
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$89.5K 0.01%
1,069
+670
+168% +$53.2K
52 53
54
55 56

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
HC
Henshaw Capital Woburn, Massachusetts $2.7B AUM 29.67% 1-Year Est. Return
CI
Capital International Los Angeles, California $2.7B AUM 31.08% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

GAMMA Investing's Q2 2025 Portfolio in Review

As of Q2 2025, GAMMA Investing held 3,941 positions worth $1.58B, up 19% from $1.33B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

GAMMA Investing deployed $113M of net new capital in Q2 2025, opening 148 new positions and adding to 2,113 existing holdings. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 33,844 shares worth $790K.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Equity Premium Income ETF, an estimated $5.77M trimmed.

  • GAMMA Investing's largest Q2 2025 buy was iShares iBonds Dec 2029 Term Corporate ETF: 33,844 shares worth $790K.
  • GAMMA Investing added most to Microsoft in Q2 2025, an estimated $13.5M increase.
  • GAMMA Investing's biggest Q2 2025 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $5.77M.
  • GAMMA Investing fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q2 2025, selling an estimated $5.06M.
  • GAMMA Investing's ten largest holdings make up 26% of its $1.58B portfolio in Q2 2025.
  • GAMMA Investing opened 148 new positions and closed 172 in Q2 2025.
  • GAMMA Investing's portfolio value rose 19% quarter-over-quarter to $1.58B.

Based on GAMMA Investing's 13F filing for Q2 2025, filed 14 Jul 2025.